Search

Scientists at Memorial Sloan Kettering are learning how to turn cancer’s appetite against itself.

… Thursday, April 1, 2021 Americans have a love-hate relationship with sugar. Our favorite foods are full of it, yet nutritionists warn that sugar provides empty calories — good for putting on weight but not much else. Cancer doctors are concerned, too, since obesity is a major risk factor for cancer.

Find out how regular screenings with CT scans can help many people who smoke.

… Tuesday, November 10, 2020 Update: On March 9, 2021, the US Preventive Services Task Force (USPSTF) issued new recommendations to expand screening for lung cancer in people who have a history of smoking but no symptoms of the disease. Under the new guidelines, screening is recommended to begin five years

… Wednesday, May 11, 2022 Barbara (“Barb”) Pemberton has a huge smile, an infectious laugh, and a great memory – she vividly remembers how scared she felt when she interviewed to be a phlebotomist in 2004. As she entered the building for the first time, on her way to “stick” someone to demonstrate her

The lack of participation in clinical research may be the Achilles heel facing today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of MSK, only 35 percent of Americans indicated that they were “likely” to enroll in a clinical trial. For more information or to schedule an interview, please contact [email protected].

… Monday, May 23, 2016 The lack of participation in clinical research may be the Achilles heel facing today’s cancer community.  According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of MSK, only 35 percent of Americans indicated that they were “likely” to

New MSK research helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to FDA approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach that shows promise in detecting lung cancer; found checkpoint inhibitors were effective against endometrial and ovarian cancers with DNA-repair deficiency; and shed new light on mTOR's role in metabolic enzyme degradation.

… Tuesday, June 25, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to Food and Drug Administration approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach

A surprising finding challenges long-held dogma about how certain immune cells develop into specialized types in diverse tissues.

… Thursday, September 8, 2016 Summary Macrophages are immune cells that exist in diverse forms in various tissues. They interact constantly with cancer cells and appear to both target them and assist them under different circumstances. A new finding sheds light on how macrophages develop into different

Learn about MSK's expertise and compassion in caring for people under 50 who are facing cancer.

… Friday, June 6, 2025 When 26-year-old Jo Luzarraga was diagnosed with breast cancer in Manila, Philippines, her older sister Jan Claire swung into action. “I told her, you’re moving to Queens, New York, to live with me and my daughter and my partner,” says Jan Claire, who is 40. “And you’re going to

Today Memorial Sloan Kettering (MSK) announced the appointment of a task force that will assess MSK policies and processes for reporting and managing outside activities and industry-supported clinical trials.

… Friday, September 21, 2018 Today Memorial Sloan Kettering (MSK) announced the appointment of a task force that will assess MSK policies and processes for reporting and managing outside activities and industry-supported clinical trials. The task force was announced in a statement from MSK President and

Learn how experimental vaccine might train the immune system to prevent pancreatic cancer from returning.

… Monday, June 10, 2024 Pancreatic cancer has long been a forbidding disease. While the five-year survival rate has inched upward in recent years, it remains quite low — about 12%. But surgeon-scientist Vinod Balachandran, MD , has focused on a glimmer of hope: A small percentage of people manage to beat

Discover what Memorial Sloan Kettering contributed to the science and medicine of x-rays.

… Tuesday, October 4, 2016 Summary Since 1902, Memorial Sloan Kettering has been a pioneer in the science and medicine of x-rays, developing many of the radiation techniques in use today. In a previous post , we recounted the history of radium therapy at Memorial Sloan Kettering. Radium, a naturally occurring